Prepared by Dr. Michael Brown, FRM, Head of Quantitative Research | Reviewed by Sofia Chen, Lead Editor | Report ID: IGEMINI-830E4488-20260531 | Data as of 2026-05-31
Executive Summary: Analysis of cash flow problems in business reveals a Cautiously Constructive configuration: technical patterns show a Bull Flag formation, while fundamentals are supported by 45.44 EPS and a 0.65% yield. Institutional flows indicate 67% ownership with beta of 0.9.
Rating: Overweight | Target Price: $3572.8 | Next Earnings: Jul 08
Download Full PDF Report
Price action carved a Bull Flag, confirmed by a 1.69x volume spike on May 11, 2026. The resistance at $3509 was tested.
MACD printed a Neutral as the 50-day SMA turned positive 8 days ago.
RSI at 48 indicates a neutral-bullish state. Historical backtests suggest a +5.2% move within 10 sessions.
EPS of $45.44 reveals resilient earnings quality. DuPont analysis highlights margin expansion as the key ROE driver.
With a market cap of $5.03B, cash flow problems in business operates in Healthcare. P/E of 70.21x is backed by -10.7% growth.
Beta of 0.9 suggests cash flow problems in business is {beta_desc} volatile than the market, influencing hedging strategies.
Short float at 4.9% is below the sector average, reducing squeeze risk. Institutional ownership is 67%.
Dark pool prints show a 16%% surge in block trades, indicating institutional accumulation before Jul 08 earnings.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $3190 | $3030.5 |
| Market Cap | $5.03B | $6.04B |
| P/E Ratio | 70.21x | 59.7x |
| EPS (TTM) | $45.44 | $40.9 |
| Dividend Yield | 0.65% | 0.5% |
| Revenue Growth | -10.7% | -6.4% |
| Target Price | $3572.8 | - |
| Beta | 0.9 | 1.00 |